Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Mersana Therapeutics buy Wedbush

Mersana Therapeutics
Start price
€0.70
11.01.25 / 50%
Target price
€3.90
11.01.26
Performance (%)
-62.70%
Price
€0.26
25.07.25
Summary
This prediction is currently active. The BUY prediction by Wedbush for Mersana Therapeutics is performing very badly with a performance of -62.70%. This prediction currently runs until 11.01.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Mersana Therapeutics - -
iShares Core DAX® 0.795% 1.458%
iShares Nasdaq 100 -3.088% -0.762%
iShares Nikkei 225® -0.952% -2.268%
iShares S&P 500 -1.393% 0.199%

Comments by Wedbush for this prediction

In the thread Mersana Therapeutics diskutieren
Prediction Buy
Perf. (%) -62.70%
Target price 3.903
Change
Ends at 11.01.26

Mersana Therapeutics, Inc. (NASDAQ: MRSN) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $4.00 price target on the stock, down previously from $7.00.
Ratings data for MRSN provided by MarketBeat

Wedbush 
0
Report Share
11.01.25

Stopped prediction by Wedbush for Mersana Therapeutics

buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€0.28
15.05.25
€2.68
15.05.26
-7.18%
25.07.25

Wedbush 
15.05.25 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€0.28
06.05.25
€2.66
06.05.26
-5.30%
25.07.25

Wedbush 
06.05.25 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€0.47
03.03.25
€3.81
03.03.26
-44.40%
25.07.25

Wedbush 
03.03.25 50%